Abstract:In order to discover highly potent alpha- glucosidase inhibitors, 20 xanthone-benzenesulfonamide derivatives were designed and synthesized. As expected, most of these derivatives exhibited good to excellent in-hibitory activities, the IC50 values of these xanthone sulfonamides varied from 0.4 +/- 0.05 to 52.2 +/- 2.1 mu M. Especially, compound 4ag showed the most potent activity (IC50 = 0.4 mu M, with 111-fold more potent than the positive control 1-deoxynojirimycin (DNJ), which is a leap compared to our previous xanthone compound. It was noteworthy that these derivatives can be competitive, noncompetitive or un-competitive inhibitors, while these inhibitory types differed by the alteration of the substituents on the benzene ring of benzenesulfonamide. To give insight into this interesting effect, further docking study was performed, indicating the flexible conformations introduced by the sulfonamide structure affect the binding site and binding mode of these compounds with the enzyme. Furthermore the uncompetitive inhibitors showed significantly stronger binding interactions with the enzyme-substrate complex than the enzyme. Additionally, the competitive inhibitor 4aj (1 mu M) exhibited a similar glucose-level decreasing and glucose up-take increasing effect com pared to DNJ (5 mu M), the positive control in HepG2 cells at five-fold lower concentration, revealing that this compound has promising hypoglycemic effect at the cellular level. (C) 2022 Published by Elsevier B.V.

Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.

Design, Synthesis and Preliminary Evaluation of New Cinnamoyl Pyrrolidine Derivatives As Potent Gelatinase Inhibitors

Synthesis and Gelatinase (MMP-2, MMP-9) Inhibitory Activities of Pyrrolidine Derivatives

Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.

Synthesis of Chiral ND-322, ND-364 and ND-364 Derivatives As Selective Inhibitors of Human Gelatinase

Design, Synthesis and Preliminary Evaluation of Α-Sulfonyl Γ-(Glycinyl-amino)proline Peptidomimetics As Matrix Metalloproteinase Inhibitors.

A Combined Molecular Modeling Study on Gelatinases and Their Potent Inhibitors

Synthesis and Neutrophil Elastase Inhibition Activities of Sivelast Analogues

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives As Α-Glucosidase Inhibitors

Synthesis, Molecular Docking and Α-Glucosidase Inhibition of 2-((5,6-Diphenyl-1,2,4-triazin-3-yl)thio)-n-arylacetamides.

Xanthone Sulfonamide Derivatives-A Novel Series of Α-Glucosidase Inhibitors with Different Inhibitory Types

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

Novel 5‐hydroxy, 5‐substituted Benzenesulfonamide Pyrimidine‐2,4,6‐Triones Attenuate Lipopolysaccharide‐Induced Acute Lung Injury Via Inhibition of the Gelatinases, MMP‐2 and MMP‐9

Design, Synthesis, and Pharmacological Evaluation of 2-(1-(1,3,4-thiadiazol-2-yl)piperidin-4-yl)ethan-1-ol Analogs As Novel Glutaminase 1 Inhibitors.

Design, Synthesis and Biological Evaluation of Novel (E)-2-benzylidene-n-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)hydrazine-1-carboxamide Derivatives As Α-Glucosidase Inhibitors.

Synthesis of NAG-thiazoline-derived Inhibitors for Β-N-acetyl-d-hexosaminidases.

Protein Catabolic Enzymes Inhibitory Activities of Pyrrolidine Derivatives

Synthesis and Evaluation of the Α-Glucosidase Inhibitory Activity of 3-[4-(phenylsulfonamido)benzoyl]-2h-1-benzopyran-2-one Derivatives

5-Thio-d-glycopyranosylamines and their amidinium salts as potential transition-state mimics of glycosyl hydrolases: synthesis, enzyme inhibitory activities, X-ray crystallography, and molecular modeling

Synthesis, Biological Activity and Docking Study of Isatin Hydrazone Derivatives as Potential alpha-Glucosidase Inhibitors

Synthesis of Benzylidene Analogs of Oleanolic Acid As Potential Α-Glucosidase and Α-Amylase Inhibitors